$1.98 Billion is the total value of Rock Springs Capital Management LP's 149 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 23.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSRO | Buy | TESARO INC | $68,601,000 | -6.1% | 490,500 | +3.3% | 3.46% | -17.8% |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $66,663,000 | +19.9% | 1,350,000 | +5.9% | 3.37% | +4.9% |
| AET | Buy | AETNA INC NEW | $58,910,000 | +109.9% | 388,000 | +76.4% | 2.98% | +83.8% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $58,222,000 | +115.1% | 314,000 | +90.3% | 2.94% | +88.2% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $56,333,000 | +1.7% | 463,000 | +1.3% | 2.84% | -11.0% |
| PCRX | Buy | PACIRA PHARMACEUTICALS INC | $49,727,000 | +9.1% | 1,042,500 | +4.2% | 2.51% | -4.6% |
| MRK | Buy | MERCK & CO INC | $48,580,000 | +1.9% | 758,000 | +1.1% | 2.45% | -10.8% |
| CI | CIGNA CORPORATION | $45,195,000 | +14.3% | 270,000 | 0.0% | 2.28% | 0.0% | |
| ISRG | INTUITIVE SURGICAL INC | $44,898,000 | +22.0% | 48,000 | 0.0% | 2.27% | +6.8% | |
| RDUS | RADIUS HEALTH INC | $41,171,000 | +17.0% | 910,250 | 0.0% | 2.08% | +2.4% | |
| AGN | Sell | ALLERGAN PLC | $37,898,000 | -4.4% | 155,900 | -6.1% | 1.91% | -16.3% |
| ONCE | SPARK THERAPEUTICS INC | $37,338,000 | +12.0% | 625,000 | 0.0% | 1.89% | -2.0% | |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $36,641,000 | -15.0% | 365,500 | +2.5% | 1.85% | -25.6% |
| MDT | New | MEDTRONIC PLC | $35,500,000 | – | 400,000 | +100.0% | 1.79% | – |
| WCG | Sell | WELLCARE HEALTH PLANS INC | $35,463,000 | +7.9% | 197,500 | -15.8% | 1.79% | -5.6% |
| PRAH | Buy | PRA HEALTH SCIENCES INC | $34,692,000 | +16.2% | 462,500 | +1.1% | 1.75% | +1.7% |
| AAAP | Sell | ADVANCED ACCELERATOR APPLICsponsored ads | $32,794,000 | -3.2% | 840,000 | -1.2% | 1.66% | -15.3% |
| HUM | HUMANA INC | $31,882,000 | +16.7% | 132,500 | 0.0% | 1.61% | +2.2% | |
| CELG | Buy | CELGENE CORP | $31,818,000 | +5.4% | 245,000 | +1.0% | 1.61% | -7.7% |
| PEN | PENUMBRA INC | $27,246,000 | +5.2% | 310,500 | 0.0% | 1.38% | -8.0% | |
| MDCO | Sell | MEDICINES CO | $26,396,000 | -22.9% | 694,446 | -0.8% | 1.33% | -32.5% |
| TBPH | THERAVANCE BIOPHARMA INC | $23,904,000 | +8.2% | 600,000 | 0.0% | 1.21% | -5.3% | |
| JNJ | JOHNSON & JOHNSON | $23,151,000 | +6.2% | 175,000 | 0.0% | 1.17% | -7.1% | |
| LOXO | Buy | LOXO ONCOLOGY INC | $23,095,000 | +203.2% | 288,000 | +59.1% | 1.17% | +165.6% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $22,495,000 | +31.5% | 1,798,195 | +5.8% | 1.14% | +15.1% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $22,466,000 | +67.6% | 190,001 | +33.3% | 1.14% | +46.8% |
| AFAM | Buy | ALMOST FAMILY INC | $22,317,000 | +104.1% | 362,000 | +60.9% | 1.13% | +78.6% |
| GILD | Buy | GILEAD SCIENCES INC | $22,182,000 | +14.0% | 313,400 | +9.4% | 1.12% | -0.3% |
| INCY | Buy | INCYTE CORP | $21,782,000 | -3.6% | 173,000 | +2.4% | 1.10% | -15.6% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $21,675,000 | +84.5% | 231,500 | +25.5% | 1.10% | +61.5% |
| MRSN | New | MERSANA THERAPEUTICS INC | $21,345,000 | – | 1,527,893 | +100.0% | 1.08% | – |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $19,274,000 | +8.6% | 419,000 | +2.2% | 0.97% | -5.0% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $19,235,000 | +7.1% | 123,700 | 0.0% | 0.97% | -6.3% | |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $19,192,000 | – | 110,000 | +100.0% | 0.97% | – |
| HOLX | Buy | HOLOGIC INC | $19,060,000 | +31.7% | 420,000 | +23.5% | 0.96% | +15.3% |
| DHR | Buy | DANAHER CORP DEL | $18,988,000 | +38.8% | 225,000 | +40.6% | 0.96% | +21.4% |
| WMGI | WRIGHT MED GROUP N V | $18,418,000 | -11.7% | 670,000 | 0.0% | 0.93% | -22.7% | |
| MOH | New | MOLINA HEALTHCARE INC | $18,229,000 | – | 263,500 | +100.0% | 0.92% | – |
| BCR | New | BARD C R INC | $18,176,000 | – | 57,500 | +100.0% | 0.92% | – |
| EPZM | Buy | EPIZYME INC | $17,743,000 | +81.5% | 1,175,000 | +106.1% | 0.90% | +58.9% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $17,128,000 | +7.0% | 4,250,000 | -15.0% | 0.86% | -6.3% |
| GLPG | Buy | GALAPAGOS NVspon adr | $16,949,000 | -6.4% | 221,500 | +5.5% | 0.86% | -18.0% |
| PRTA | PROTHENA CORP PLC | $16,750,000 | -3.0% | 309,500 | 0.0% | 0.85% | -15.1% | |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $16,624,000 | +68.0% | 129,000 | +42.5% | 0.84% | +46.9% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $16,256,000 | +362.5% | 186,000 | +96.8% | 0.82% | +304.4% |
| WLTW | WILLIS TOWERS WATSON PUB LTD | $16,001,000 | +11.1% | 110,000 | 0.0% | 0.81% | -2.8% | |
| EXAS | Buy | EXACT SCIENCES CORP | $15,474,000 | +94.1% | 437,500 | +29.6% | 0.78% | +69.8% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $14,460,000 | +42.9% | 600,000 | +14.2% | 0.73% | +25.0% |
| AVXS | Buy | AVEXIS INC | $14,378,000 | +35.1% | 175,000 | +25.0% | 0.73% | +18.2% |
| BIIB | Buy | BIOGEN INC | $14,382,000 | +9.6% | 53,000 | +10.4% | 0.73% | -4.1% |
| BAX | New | BAXTER INTL INC | $13,924,000 | – | 230,000 | +100.0% | 0.70% | – |
| HLS | HEALTHSOUTH CORP | $12,826,000 | +13.1% | 265,000 | 0.0% | 0.65% | -1.1% | |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $11,933,000 | -40.7% | 440,000 | -34.8% | 0.60% | -48.1% |
| BGNE | BEIGENE LTDsponsored adr | $11,925,000 | +22.9% | 265,000 | 0.0% | 0.60% | +7.5% | |
| NVTA | INVITAE CORP | $11,472,000 | -13.6% | 1,200,000 | 0.0% | 0.58% | -24.4% | |
| RTIX | Buy | RTI SURGICAL INC | $11,408,000 | +53.3% | 1,950,000 | +4.8% | 0.58% | +34.3% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $11,386,000 | +33.6% | 595,200 | +19.0% | 0.58% | +16.9% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11,353,000 | +3.5% | 125,000 | 0.0% | 0.57% | -9.5% | |
| DERM | DERMIRA INC | $11,295,000 | -14.6% | 387,600 | 0.0% | 0.57% | -25.3% | |
| RARX | Sell | RA PHARMACEUTICALS INC | $11,244,000 | -33.1% | 600,000 | -24.0% | 0.57% | -41.4% |
| ARDX | ARDELYX INC | $10,200,000 | -59.7% | 2,000,000 | 0.0% | 0.52% | -64.7% | |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $9,957,000 | -30.3% | 693,900 | +2.8% | 0.50% | -39.0% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $9,969,000 | -7.9% | 160,500 | +0.5% | 0.50% | -19.5% |
| XENT | INTERSECT ENT INC | $9,643,000 | +63.0% | 345,000 | 0.0% | 0.49% | +42.8% | |
| FGEN | Buy | FIBROGEN INC | $9,044,000 | +52.9% | 280,000 | +16.7% | 0.46% | +34.0% |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $9,022,000 | -0.9% | 325,000 | 0.0% | 0.46% | -13.1% | |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $8,780,000 | +153.4% | 540,000 | +140.0% | 0.44% | +121.5% |
| CLSD | CLEARSIDE BIOMEDICAL INC | $8,518,000 | +14.7% | 935,000 | 0.0% | 0.43% | +0.5% | |
| TXMD | THERAPEUTICSMD INC | $8,432,000 | -26.8% | 1,600,000 | 0.0% | 0.43% | -35.9% | |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $8,375,000 | – | 105,000 | +100.0% | 0.42% | – |
| CO | CHINA CORD BLOOD CORP | $8,342,000 | +42.3% | 880,000 | 0.0% | 0.42% | +24.6% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $8,054,000 | -19.0% | 390,000 | 0.0% | 0.41% | -29.1% | |
| INSM | INSMED INC | $8,031,000 | -2.0% | 468,000 | 0.0% | 0.41% | -14.2% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $7,918,000 | +25.4% | 1,725,000 | +15.0% | 0.40% | +9.9% |
| PTLA | New | PORTOLA PHARMACEUTICALS INCcall | $7,864,000 | – | 140,000 | +100.0% | 0.40% | – |
| REGN | Buy | REGENERON PHARMACEUTICALS | $7,858,000 | +34.3% | 16,000 | +6.0% | 0.40% | +17.5% |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $7,847,000 | – | 139,700 | +100.0% | 0.40% | – |
| RTRX | RETROPHIN INC | $7,756,000 | +5.0% | 400,000 | 0.0% | 0.39% | -8.0% | |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $7,675,000 | – | 307,000 | +100.0% | 0.39% | – |
| FOLD | AMICUS THERAPEUTICS INC | $7,628,000 | +41.2% | 757,500 | 0.0% | 0.38% | +23.4% | |
| OBSV | Buy | OBSEVA SA | $7,182,000 | -17.7% | 840,000 | +0.2% | 0.36% | -28.0% |
| Buy | NEURODERM LTD | $7,107,000 | +218.4% | 237,700 | +182.7% | 0.36% | +178.3% | |
| KITE | Buy | KITE PHARMA INC | $6,998,000 | +33.1% | 67,500 | +0.7% | 0.35% | +16.5% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $6,911,000 | +20.4% | 205,000 | +5.7% | 0.35% | +5.4% |
| JUNO | Buy | JUNO THERAPEUTICS INC | $6,725,000 | +53.9% | 225,000 | +14.2% | 0.34% | +34.9% |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $6,735,000 | -49.6% | 86,000 | -46.6% | 0.34% | -56.0% |
| LXRX | New | LEXICON PHARMACEUTICALS INCcall | $6,473,000 | – | 393,500 | +100.0% | 0.33% | – |
| MRUS | Buy | MERUS N V | $6,372,000 | -32.1% | 402,000 | +4.5% | 0.32% | -40.5% |
| AXGN | New | AXOGEN INC | $6,281,000 | – | 375,000 | +100.0% | 0.32% | – |
| AIMT | AIMMUNE THERAPEUTICS INC | $6,024,000 | -5.4% | 293,000 | 0.0% | 0.30% | -17.2% | |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $5,932,000 | -0.6% | 197,000 | +19.4% | 0.30% | -12.8% |
| STE | Buy | STERIS PLC | $5,909,000 | +30.9% | 72,500 | +11.5% | 0.30% | +14.2% |
| New | NABRIVA THERAPEUTICS PLC | $5,502,000 | – | 525,000 | +100.0% | 0.28% | – | |
| GTHX | New | G1 THERAPEUTICS INC | $5,445,000 | – | 312,188 | +100.0% | 0.28% | – |
| CRME | CARDIOME PHARMA CORP | $5,424,000 | +50.2% | 1,200,000 | 0.0% | 0.27% | +31.7% | |
| New | MEDICINES COnote 2.750% 7/1 | $5,256,000 | – | 5,000,000 | +100.0% | 0.26% | – | |
| SGEN | New | SEATTLE GENETICS INC | $5,174,000 | – | 100,000 | +100.0% | 0.26% | – |
| CRVS | CORVUS PHARMACEUTICALS INC | $5,113,000 | -41.7% | 422,600 | 0.0% | 0.26% | -49.0% | |
| EGALET CORPnote 5.500% 4/0 | $5,002,000 | -22.5% | 7,800,000 | 0.0% | 0.25% | -32.0% | ||
| TTPH | TETRAPHASE PHARMACEUTICALS I | $4,977,000 | -22.4% | 698,000 | 0.0% | 0.25% | -32.2% | |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $4,853,000 | – | 174,000 | +100.0% | 0.24% | – |
| ADRO | ADURO BIOTECH INC | $4,731,000 | +6.1% | 415,000 | 0.0% | 0.24% | -7.0% | |
| AGNPRA | ALLERGAN PLCpfd conv ser a | $4,336,000 | +2.2% | 5,000 | 0.0% | 0.22% | -10.6% | |
| EXEL | EXELIXIS INC | $4,310,000 | +13.7% | 175,000 | 0.0% | 0.22% | -0.5% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $4,103,000 | -25.8% | 150,000 | 0.0% | 0.21% | -35.1% | |
| OTIC | OTONOMY INC | $3,959,000 | +53.9% | 210,000 | 0.0% | 0.20% | +35.1% | |
| MGNX | MACROGENICS INC | $3,940,000 | -5.9% | 225,000 | 0.0% | 0.20% | -17.4% | |
| MEDICINES COnote 2.500% 1/1 | $3,913,000 | -17.5% | 3,000,000 | 0.0% | 0.20% | -27.7% | ||
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $3,929,000 | -18.5% | 875,000 | 0.0% | 0.20% | -28.8% | |
| HRC | HILL ROM HLDGS INC | $3,582,000 | +12.7% | 45,000 | 0.0% | 0.18% | -1.1% | |
| ALGN | New | ALIGN TECHNOLOGY INC | $3,453,000 | – | 23,000 | +100.0% | 0.17% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $3,362,000 | +21.3% | 32,000 | +4.9% | 0.17% | +6.2% |
| CGEN | COMPUGEN LTDord | $3,135,000 | -11.6% | 825,000 | 0.0% | 0.16% | -22.9% | |
| ALKS | Sell | ALKERMES PLC | $3,014,000 | -58.8% | 52,000 | -58.4% | 0.15% | -64.0% |
| AXGT | New | AXOVANT SCIENCES LTD | $2,899,000 | – | 125,000 | +100.0% | 0.15% | – |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $2,786,000 | -88.7% | 50,000 | -89.0% | 0.14% | -90.1% |
| RIGL | RIGEL PHARMACEUTICALS INC | $2,730,000 | -17.5% | 1,000,000 | 0.0% | 0.14% | -27.7% | |
| ZBH | ZIMMER BIOMET HLDGS INC | $2,709,000 | +5.1% | 21,100 | 0.0% | 0.14% | -8.1% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $2,607,000 | +1.4% | 73,000 | 0.0% | 0.13% | -10.8% | |
| GKOS | GLAUKOS CORP | $2,592,000 | -19.2% | 62,500 | 0.0% | 0.13% | -29.2% | |
| INVA | Sell | INNOVIVA INC | $2,560,000 | -21.2% | 200,000 | -14.9% | 0.13% | -31.4% |
| HQY | Buy | HEALTHEQUITY INC | $2,541,000 | +19.7% | 51,000 | +2.0% | 0.13% | +4.9% |
| GLYC | New | GLYCOMIMETICS INC | $2,511,000 | – | 225,000 | +100.0% | 0.13% | – |
| GNCA | GENOCEA BIOSCIENCES INC | $2,506,000 | -14.3% | 480,000 | 0.0% | 0.13% | -24.9% | |
| MCRB | SERES THERAPEUTICS INC | $2,486,000 | +0.3% | 220,000 | 0.0% | 0.13% | -11.9% | |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $2,329,000 | -24.6% | 187,500 | -1.3% | 0.12% | -33.7% |
| CDTX | CIDARA THERAPEUTICS INC | $2,250,000 | -3.8% | 300,000 | 0.0% | 0.11% | -15.6% | |
| PTI | PROTEOSTASIS THERAPEUTICS IN | $2,106,000 | -40.2% | 450,000 | 0.0% | 0.11% | -47.8% | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $2,084,000 | -45.0% | 182,000 | 0.0% | 0.10% | -51.8% | |
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $2,032,000 | +7.0% | 1,500,000 | 0.0% | 0.10% | -6.4% | ||
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $2,013,000 | -48.4% | 524,089 | 0.0% | 0.10% | -54.7% | |
| NVDQ | Sell | NOVADAQ TECHNOLOGIES INC | $1,758,000 | -59.3% | 150,000 | -73.0% | 0.09% | -64.3% |
| MYOV | MYOVANT SCIENCES LTD | $1,755,000 | -0.3% | 150,000 | 0.0% | 0.09% | -12.7% | |
| LIFE | ATYR PHARMA INC | $1,615,000 | -2.9% | 475,000 | 0.0% | 0.08% | -14.6% | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $1,592,000 | +62.1% | 165,000 | 0.0% | 0.08% | +40.4% | |
| NVLS | NIVALIS THERAPEUTICS INC | $1,446,000 | -17.5% | 600,000 | 0.0% | 0.07% | -27.7% | |
| SCYX | SCYNEXIS INC | $1,360,000 | -35.2% | 760,000 | 0.0% | 0.07% | -43.0% | |
| WRIGHT MED GROUP INCnote 2.000% 2/1 | $1,116,000 | -6.8% | 1,000,000 | 0.0% | 0.06% | -18.8% | ||
| NVAX | NOVAVAX INC | $943,000 | -10.2% | 820,000 | 0.0% | 0.05% | -21.3% | |
| PRGO | Sell | PERRIGO CO PLC | $740,000 | -28.6% | 9,800 | -37.2% | 0.04% | -38.3% |
| EGLTQ | EGALET CORP | $711,000 | -53.5% | 300,000 | 0.0% | 0.04% | -59.1% | |
| CHMA | CHIASMA INC | $714,000 | -14.7% | 492,500 | 0.0% | 0.04% | -25.0% | |
| NLNK | Buy | NEWLINK GENETICS CORP | $533,000 | -67.0% | 72,500 | +8.1% | 0.03% | -71.0% |
| OREXQ | OREXIGEN THERAPEUTICS INC | $479,000 | -15.8% | 165,300 | 0.0% | 0.02% | -27.3% | |
| TNDM | Sell | TANDEM DIABETES CARE INC | $450,000 | -37.0% | 562,500 | -5.5% | 0.02% | -43.9% |
| INFI | INFINITY PHARMACEUTICALS INC | $424,000 | -51.4% | 270,000 | 0.0% | 0.02% | -58.0% | |
| DMTX | DIMENSION THERAPEUTICS INC | $393,000 | -17.3% | 271,370 | 0.0% | 0.02% | -25.9% | |
| ANTH | New | ANTHERA PHARMACEUTICALS INC | $268,000 | – | 165,705 | +100.0% | 0.01% | – |
| CERU | CERULEAN PHARMA INC | $276,000 | -45.7% | 625,000 | 0.0% | 0.01% | -51.7% | |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -1,296,568 | -100.0% | -0.03% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -66,400 | -100.0% | -0.04% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -214,316 | -100.0% | -0.10% | – |
| CARA | Exit | CARA THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.16% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.30% | – |
| NBRV | Exit | NABRIVA THERAPEUTICS AGsponsored adr | $0 | – | -525,000 | -100.0% | -0.36% | – |
| ATHN | Exit | ATHENAHEALTH INC | $0 | – | -62,750 | -100.0% | -0.41% | – |
| EVHC | Exit | ENVISION HEALTHCARE CORP | $0 | – | -145,000 | -100.0% | -0.51% | – |
| PTHN | Exit | PATHEON N V | $0 | – | -400,000 | -100.0% | -0.61% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -98,000 | -100.0% | -0.93% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -138,900 | -100.0% | -1.40% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -325,000 | -100.0% | -1.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.